1. $SNSS just was for last 5 to 10 minutes before EOD for this to bounce back up to $1

  2. $SNSS new study on untreated patients will show real result data on effectiveness and other things they are looking at #SNSS #profit

  3. $SNSS I think I am going to put an order in for 60k shares at $.95 and see if I get any today ir next couple of days.

  4. $SNSS this will bounce back up to at least $1 by EOD, whether naturally or by company executive manipulation

  5. The primary endpoint of the study is rate of complete remission, including complete remission with incomplete blood count recovery. $SNSS

  6. older w/ previously untreated acute myeloid leukemia. $SNSS

  7. $SNSS If this doesn t close over 1, it will have to start the consecutive day requirement all over again to avoid delisting.

  8. Sunesis Pharma ($SNSS) First patient treated in an investigator-sponsored pilot study of Vosaroxin & Oytarabine in adult pts age 60 yrs and

  9. $SNSS Got SNSS for 0.95. Stop is 0.94

  10. *Sunesis Pharma Initiates IU Pilot Study Of Vosaroxin, Cytarabine Treatment In ~17 Patients 60 Years or Older With Untreated AML $SNSS

  11. My Watches for 12/1 (Short and Long): $NCTY $RPRX $FOLD $EFUT $CLVS $AXPW $GENE $KBIO $AVXL $GLBL $SNSS $ETSY $GENE

  12. $SNSS Any upcoming expectations for FDA approval or submission?

  13. $SNSS Hopefully it can stay above 1 for at least long enough to avoid delisting!

  14. $SNSS this baby needs some cheerleaders! today s news should be shouted from roofs...

  15. $SNSS steady rise at reasonable volume

  16. Top % Gainers: $CNIT 43%, $HART 28%, $AVXL 28%, $ORMP 26%, $HCLP 22%, $XCO 13%, $CLDN 13%, $KANG 12% $EMES $JMEI $VNCE $OHGI $SNSS $IPCI

  17. I lived once in fear. Now I m back for good to be rich, with no fear: $CLDN, $DCTH, $CYCC, $SNSS, $ARO, $PSUN, $WGBS, $XOMA, $CYTX lets go

  18. Top % Gainers: $ORMP 31%, $AVXL 22%, $WGBS 22%, $KANG 14%, $HART 12%, $CNIT $JMEI $GERN $SNSS $CANF $IDRA $NVAX $CSRA $MNGA $QUNR $WB $LSCC

  19. $SNSS great News, may see $3 soon.

  20. Top % Gainers: $ORMP 31%, $WGBS 25%, $AVXL 22%, $KANG 15%, $GILT 14%, $GURE 10%, $OHGI 10% $GIGA $WMGI $CNIT $SNSS $CANF $FIZZ $IDRA $TACO

  21. $SNSS European Patent Covering Vosaroxin Combination Use In AML And Other Hematologic Malignancies (Healthcare)

  22. Premarket Top % Gainers: $WGBS 28%, $AVXL 20%, $KANG 19%, $ORMP 17%, $OHGI 16%, $SNSS 13%, $GILT 12% $CANF $CSC $HZNP $MNGA $MBT $BZQ $FIT


  24. Premarket Top % Gainers: $WGBS 33%, $AVXL 26%, $ORMP 19%, $KANG 18%, $OHGI 16%, $SNSS 13%, $GILT 12%, $CANF 10% $GGAL $CSC $MNGA $DVAX $HZNP

  25. Premarket Top % Gainers: $WGBS 32%, $KANG 16%, $GILT 14%, $SNSS 13%, $AVXL 11%, $OHGI 10%, $GGAL 7%, $ABGB 7%, $CANF 5% $MNGA $DVAX $SCVL